Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010077613) MODULATORS OF TOLL-LIKE RECEPTORS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/077613 International Application No.: PCT/US2009/067002
Publication Date: 08.07.2010 International Filing Date: 07.12.2009
Chapter 2 Demand Filed: 09.09.2010
IPC:
C07D 475/06 (2006.01) ,C07D 475/08 (2006.01) ,C07D 475/12 (2006.01) ,C07D 487/04 (2006.01) ,A61K 31/519 (2006.01) ,A61P 31/12 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
475
Heterocyclic compounds containing pteridine ring systems
06
with a nitrogen atom directly attached in position 4
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
475
Heterocyclic compounds containing pteridine ring systems
06
with a nitrogen atom directly attached in position 4
08
with a nitrogen atom directly attached in position 2
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
475
Heterocyclic compounds containing pteridine ring systems
12
containing pteridine ring systems condensed with carbocyclic rings or ring systems
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
GILEAD SCIENCES, INC. [US/US]; 333 Lakeside Drive Foster City, CA 94404, US (AllExceptUS)
DESAI, Manoj, C. [US/US]; US (UsOnly)
HALCOMB, Randall, L. [US/US]; US (UsOnly)
HRVATIN, Paul [US/US]; US (UsOnly)
HUI, Hon Chung [US/US]; US (UsOnly)
MC FADDEN, Ryan [US/US]; US (UsOnly)
ROETHLE, Paul, A. [US/US]; US (UsOnly)
YANG, Hong [CN/US]; US (UsOnly)
Inventors:
DESAI, Manoj, C.; US
HALCOMB, Randall, L.; US
HRVATIN, Paul; US
HUI, Hon Chung; US
MC FADDEN, Ryan; US
ROETHLE, Paul, A.; US
YANG, Hong; US
Agent:
WARD, John, S.; Gilead Sciences, Inc 333 Lakeside Drive Foster City, CA 94404, US
Priority Data:
61/121,06109.12.2008US
61/170,40417.04.2009US
61/224,38609.07.2009US
61/227,37821.07.2009US
61/242,63515.09.2009US
Title (EN) MODULATORS OF TOLL-LIKE RECEPTORS
(FR) MODULATEURS DE RÉCEPTEURS DE TYPE TOLL (TLR)
Abstract:
(EN) Provided are modulators of TLRs of Formula (II): pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
(FR) L'invention porte sur des modulateurs de TLR représentés par la Formule (II) : sur des sels pharmaceutiquement acceptables de ceux-ci, sur des compositions contenant de tels composés et sur des procédés thérapeutiques qui comprennent l'administration de tels composés.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
RSP-2014/0303UAa201108585EP2364314IL213101MXMX/a/2011/006152SG172060
JP2012511577CN102272134CA2745295EA201190021ES2467108EP2818469
IL236272KR1020110098809NZ593110DK2364314BRPI0923305AU2009333559
KR1020160142898VN28008ID2012/02429EP3210982IN4145/DELNP/2011